News | April 27, 2012

New Report Shows Potential for Health Care Savings in Nuclear and Molecular Imaging

April 27, 2012 — Amidst growing concerns over healthcare costs, the Society of Nuclear Medicine (SNM) is offering a solution to help cut back on federal spending in its new report, “Imaging with CARE.” According to the report, an estimated $1.32 billion could be saved on nuclear and molecular imaging procedures over the next 10 years by taking steps to reduce the number of repeated scans due to poor quality images.

Approximately 130 million diagnostic radiology procedures—including X-rays, magnetic resonance imaging (MRI), computed tomography (CT) and nuclear medicine scans—are performed on 30 million Medicare enrollees each year. According to the Government Accountability Office, nuclear and molecular imaging scans account for $2.4 billion in costs. With an estimated four to seven percent of these procedures repeated due to poor imaging, Medicare spends $132 million in avoidable scans each year.

“Having to repeat a nuclear or molecular imaging scan because of the poor quality of the original image is something that shouldn’t happen and something that can be fixed,” said Ann Marie Alessi, BS, CNMT, NCT, RT(N), president of SNM’s Technologist Section. “By ensuring that the technologists performing these scans have appropriate training and education, Congress can ensure that most of these repeated scans are avoided.”

Each year an estimated 17 million nuclear medicine and molecular imaging procedures are performed in hospitals and medical settings across the United States. Nuclear medicine procedures use radioactive substances to visualize the molecular processes through which the body functions. This provides physicians with unique data that can help personalize treatment for heart disease, cancer, brain disorders and other diseases.

Currently only 30 states and the District of Columbia[1] have certification or licensure provisions for nuclear medicine and molecular imaging technologists that require them to be certified by a national credentialing organization. Twenty states[2] do not regulate this profession at all.

“Many state regulations also include continuing education requirements,” added Alessi. “With new technologies upon us every year, it’s critical that nuclear medicine and molecular imaging technologists are up-to-date on the techniques needed to appropriately perform the imaging scans.”

Poor quality scans can also result in misdiagnosis of disease, delays in treatment and unnecessary anxiety for the patient. If additional testing is required, patients are exposed to an increased amount of radiation. While imaging can be an invaluable tool, the procedures do carry a potential health risk, and radiation can be harmful if administered improperly.

To improve the quality of medical imaging, the Consistency, Accuracy, Responsibility and Excellence in Medical Imaging (CARE) bill has been introduced in Congress. If enacted, the bill would establish minimum education and certification standards for personnel who perform nuclear medicine and molecular imaging procedures. As a result, institutions that provide medical imaging or radiation therapy to Medicare patients would be required to employ personnel who meet or exceed the standards set by the federal government.

The CARE bill is supported by the Alliance for Quality Medical Imaging and Radiation Therapy, a group co-founded by SNM, its Technologist Section and the American Society of Radiologic Technologists in 1998. Since then, an additional 20 organizations have joined the alliance; together, the 23 groups represent more than 500,000 health care professionals. The bill currently has 89 co-sponsors, and it is expected that companion legislation will be introduced in the U.S. Senate.

For more information: www.snm.org/CARE

1 Arizona, Arkansas, California, Delaware, District of Columbia, Florida, Hawaii, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Mississippi, New Jersey, New Mexico, New York, Ohio, Oregon, Pennsylvania, Rhode Island, South Carolina, Texas, Utah, Vermont, Washington, West Virginia, Wyoming.

2 Alabama, Alaska, Colorado, Connecticut, Georgia, Idaho, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, North Carolina, North Dakota, Oklahoma, South Dakota, Tennessee, Virginia, Wisconsin.

Related Content

Siemens Healthineers Announces FDA Clearance of syngo.via VB30 Molecular Imaging Software
Technology | Nuclear Imaging | July 16, 2018
At the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 23-26 in Philadelphia...
SNMMI Image of the Year Highlights Theranostic Approach for Advanced Prostate Cancer

IMAGE OF THE YEAR: PSMA PET before and after lutetium-177 PSMA617 theranostics in 8 patients with metastatic prostate cancer who exhausted standard therapeutic options.

68Ga-PSMA11 PET maximum intensity projection (MIP) images at baseline and 3 months after 177Lu-PSMA617 in 8 patients with PSA decline ≥ 98 percent in a prospective phase II study. Any disease with SUV over 3 is in red. Credit: Michael Hofman, John Violet, Shahneen Sandhu, Justin Ferdinandus, Amir Iravani, Grace Kong, Aravind Ravi Kumar, Tim Akhurst, Sue Ping Thang, Price Jackson, Mark Scalzo, Scott Williams and Rodney Hicks, Peter MacCallum Cancer Centre, Melbourne, Australia.

News | PET Imaging | June 29, 2018
In the battle against metastatic castrate-resistant prostate cancer, studies have demonstrated a high response rate to...
MILabs Introduces Futuristic PET Capabilities on New VECTor6 System
Technology | PET Imaging | June 28, 2018
At the 2018 Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting, June 23-26, in Philadelphia,...
Philips North America and GE Healthcare Win IMV PET Imaging ServiceTrak Awards
News | PET Imaging | June 25, 2018
IMV, part of the Science and Medicine Group and a market research and business intelligence provider to the imaging...
New ASNC SPECT Imaging Guideline Addresses Advances in Myocardial Perfusion Imaging
News | SPECT Imaging | June 21, 2018
The American Society of Nuclear Cardiology (ASNC) has published an update to its 2010 guidelines for single photon...
FDA Clears New Imaging Functionalities for Biograph mCT PET/CT Systems
Technology | PET-CT | June 21, 2018
Siemens Healthineers will announce U.S. Food and Drug Administration (FDA) clearance of four new system features for...
PET/CT Changes Care for 59 Percent of Suspected Recurrent Prostate Cancer Cases
News | Prostate Cancer | June 13, 2018
A recently presented investigational clinical trial evaluated the impact of 18F fluciclovine positron emission...
Nuclear imaging scan showing very good tissue delineation. Scan performed on a Biograph Vision positron emission tomography/computed tomography (PET-CT) system from Siemens Healthineers.

Nuclear imaging scan showing very good tissue delineation. It offers crisp overall image quality and sharply delineates the muscle and fat planes, vertebral margins and end plates, billiary radicals, renal calyces, aortic wall and papillary muscles of the heart. Scan performed on a Biograph Vision positron emission tomography/computed tomography (PET-CT) system from Siemens Healthineers.

Technology | PET-CT | June 05, 2018
June 5, 2018 — The U.S.
Emerging Trends in Nuclear Medicine
Feature | Nuclear Imaging | June 04, 2018 | By Jeff Zagoudis
Nuclear imaging and its various modalities have long played an important role in the diagnosis and treatment of numer
Overlay Init